 CELEBRATION, Fla., Aug. 02, 2022 GLOBE NEWSWIRE -- KemPharm, Inc. NasdaqGS: KMPH KemPharm, or the Company, a specialty pharmaceutical company focused on the discovery, development and commercialization of novel treatments for rare central nervous system CNS, neurodegenerative and lysosomal storage diseases, today announced that Richard W. Pascoe, Executive Chairman of KemPharm, will present at the Canaccord Genuity 42nd Annual Growth Conference being held August 8-11, 2022, in Boston. 